NOLUDAR Drug Patent Profile
✉ Email this page to a colleague
When do Noludar patents expire, and what generic alternatives are available?
Noludar is a drug marketed by Roche and is included in one NDA.
The generic ingredient in NOLUDAR is methyprylon. Additional details are available on the methyprylon profile page.
Summary for NOLUDAR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 15 |
Patent Applications: | 1,560 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NOLUDAR at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for NOLUDAR
US Patents and Regulatory Information for NOLUDAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche | NOLUDAR | methyprylon | CAPSULE;ORAL | 009660-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roche | NOLUDAR | methyprylon | TABLET;ORAL | 009660-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roche | NOLUDAR | methyprylon | ELIXIR;ORAL | 009660-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roche | NOLUDAR | methyprylon | TABLET;ORAL | 009660-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |